nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—DRD5—bipolar disorder	0.159	0.205	CbGaD
Dopamine—COMT—bipolar disorder	0.1	0.129	CbGaD
Dopamine—DRD4—bipolar disorder	0.0814	0.105	CbGaD
Dopamine—MAOA—bipolar disorder	0.0758	0.0977	CbGaD
Dopamine—DRD3—bipolar disorder	0.0702	0.0905	CbGaD
Dopamine—DRD1—bipolar disorder	0.0689	0.0888	CbGaD
Dopamine—SLC6A3—bipolar disorder	0.0653	0.0842	CbGaD
Dopamine—HTR1A—bipolar disorder	0.0572	0.0738	CbGaD
Dopamine—SLC6A4—bipolar disorder	0.0489	0.063	CbGaD
Dopamine—DRD2—bipolar disorder	0.0486	0.0626	CbGaD
Dopamine—DBH—locus ceruleus—bipolar disorder	0.01	0.122	CbGeAlD
Dopamine—DBH—autonomic nervous system—bipolar disorder	0.00534	0.065	CbGeAlD
Dopamine—DRD3—telencephalic ventricle—bipolar disorder	0.00391	0.0476	CbGeAlD
Dopamine—SLC6A2—locus ceruleus—bipolar disorder	0.00383	0.0466	CbGeAlD
Dopamine—HTR7—locus ceruleus—bipolar disorder	0.00369	0.0449	CbGeAlD
Dopamine—MAOA—locus ceruleus—bipolar disorder	0.00352	0.0429	CbGeAlD
Dopamine—POU5F1—cerebellum—bipolar disorder	0.00335	0.0408	CbGeAlD
Dopamine—DRD1—telencephalic ventricle—bipolar disorder	0.0028	0.0341	CbGeAlD
Dopamine—COMT—telencephalic ventricle—bipolar disorder	0.00252	0.0307	CbGeAlD
Dopamine—SLC6A3—telencephalic ventricle—bipolar disorder	0.00225	0.0274	CbGeAlD
Dopamine—SLC6A2—autonomic nervous system—bipolar disorder	0.00203	0.0248	CbGeAlD
Dopamine—HTR7—autonomic nervous system—bipolar disorder	0.00196	0.0239	CbGeAlD
Dopamine—HTR1A—telencephalic ventricle—bipolar disorder	0.00183	0.0223	CbGeAlD
Dopamine—HTR7—telencephalic ventricle—bipolar disorder	0.00175	0.0213	CbGeAlD
Dopamine—DRD2—telencephalic ventricle—bipolar disorder	0.00165	0.0201	CbGeAlD
Dopamine—CYP2C19—urine—bipolar disorder	0.00156	0.019	CbGeAlD
Dopamine—CYP1A2—urine—bipolar disorder	0.00127	0.0155	CbGeAlD
Dopamine—CYP2C9—urine—bipolar disorder	0.00121	0.0147	CbGeAlD
Dopamine—COMT—blood plasma—bipolar disorder	0.0012	0.0146	CbGeAlD
Dopamine—DBH—adrenal cortex—bipolar disorder	0.00115	0.014	CbGeAlD
Dopamine—SLC6A4—blood plasma—bipolar disorder	0.000982	0.012	CbGeAlD
Dopamine—MAOB—blood plasma—bipolar disorder	0.000934	0.0114	CbGeAlD
Dopamine—CYP2D6—urine—bipolar disorder	0.000907	0.011	CbGeAlD
Dopamine—HTR1A—blood plasma—bipolar disorder	0.000872	0.0106	CbGeAlD
Dopamine—HTR7—blood plasma—bipolar disorder	0.000833	0.0101	CbGeAlD
Dopamine—Dobutamine—COMT—bipolar disorder	0.000826	0.223	CrCbGaD
Dopamine—Methyldopa—COMT—bipolar disorder	0.000826	0.223	CrCbGaD
Dopamine—CYP2C19—blood plasma—bipolar disorder	0.000814	0.00991	CbGeAlD
Dopamine—MAOA—blood plasma—bipolar disorder	0.000797	0.0097	CbGeAlD
Dopamine—L-DOPA—DRD5—bipolar disorder	0.000687	0.185	CrCbGaD
Dopamine—DBH—nervous system—bipolar disorder	0.000675	0.00822	CbGeAlD
Dopamine—CYP1A2—blood plasma—bipolar disorder	0.000665	0.00809	CbGeAlD
Dopamine—DBH—cerebellum—bipolar disorder	0.000635	0.00774	CbGeAlD
Dopamine—CYP2C9—blood plasma—bipolar disorder	0.000631	0.00768	CbGeAlD
Dopamine—COMT—adrenal cortex—bipolar disorder	0.000609	0.00742	CbGeAlD
Dopamine—DRD4—brain—bipolar disorder	0.000602	0.00733	CbGeAlD
Dopamine—DRD3—nervous system—bipolar disorder	0.000554	0.00674	CbGeAlD
Dopamine—DRD5—nervous system—bipolar disorder	0.000519	0.00632	CbGeAlD
Dopamine—DBH—brain—bipolar disorder	0.000516	0.00628	CbGeAlD
Dopamine—MAOB—adrenal cortex—bipolar disorder	0.000474	0.00577	CbGeAlD
Dopamine—CYP2D6—blood plasma—bipolar disorder	0.000473	0.00576	CbGeAlD
Dopamine—COMT—thyroid gland—bipolar disorder	0.000424	0.00517	CbGeAlD
Dopamine—DRD3—brain—bipolar disorder	0.000423	0.00516	CbGeAlD
Dopamine—MAOA—adrenal cortex—bipolar disorder	0.000404	0.00492	CbGeAlD
Dopamine—DRD5—brain—bipolar disorder	0.000397	0.00483	CbGeAlD
Dopamine—DRD1—nervous system—bipolar disorder	0.000397	0.00483	CbGeAlD
Dopamine—SLC22A5—adrenal cortex—bipolar disorder	0.000372	0.00453	CbGeAlD
Dopamine—COMT—nervous system—bipolar disorder	0.000357	0.00435	CbGeAlD
Dopamine—SLC22A3—thyroid gland—bipolar disorder	0.000357	0.00434	CbGeAlD
Dopamine—L-DOPA—DRD4—bipolar disorder	0.000351	0.0947	CrCbGaD
Dopamine—COMT—cerebellum—bipolar disorder	0.000336	0.00409	CbGeAlD
Dopamine—MAOB—thyroid gland—bipolar disorder	0.00033	0.00402	CbGeAlD
Dopamine—SLC6A3—nervous system—bipolar disorder	0.000319	0.00388	CbGeAlD
Dopamine—SLC22A1—nervous system—bipolar disorder	0.000314	0.00382	CbGeAlD
Dopamine—DRD1—brain—bipolar disorder	0.000303	0.00369	CbGeAlD
Dopamine—L-DOPA—DRD3—bipolar disorder	0.000303	0.0817	CrCbGaD
Dopamine—ADRB1—nervous system—bipolar disorder	0.000302	0.00368	CbGeAlD
Dopamine—SLC22A3—nervous system—bipolar disorder	0.0003	0.00365	CbGeAlD
Dopamine—SLC6A3—cerebellum—bipolar disorder	0.0003	0.00365	CbGeAlD
Dopamine—L-DOPA—DRD1—bipolar disorder	0.000297	0.0802	CrCbGaD
Dopamine—SLC6A4—nervous system—bipolar disorder	0.000292	0.00356	CbGeAlD
Dopamine—MAOA—thyroid gland—bipolar disorder	0.000282	0.00343	CbGeAlD
Dopamine—MAOB—nervous system—bipolar disorder	0.000278	0.00338	CbGeAlD
Dopamine—COMT—brain—bipolar disorder	0.000273	0.00332	CbGeAlD
Dopamine—MAOB—cerebellum—bipolar disorder	0.000261	0.00318	CbGeAlD
Dopamine—SLC22A5—thyroid gland—bipolar disorder	0.000259	0.00316	CbGeAlD
Dopamine—HTR1A—nervous system—bipolar disorder	0.000259	0.00316	CbGeAlD
Dopamine—SLC6A2—nervous system—bipolar disorder	0.000257	0.00313	CbGeAlD
Dopamine—HTR7—nervous system—bipolar disorder	0.000248	0.00302	CbGeAlD
Dopamine—HTR1A—cerebellum—bipolar disorder	0.000244	0.00297	CbGeAlD
Dopamine—SLC6A3—brain—bipolar disorder	0.000244	0.00297	CbGeAlD
Dopamine—SLC22A1—brain—bipolar disorder	0.00024	0.00292	CbGeAlD
Dopamine—MAOA—nervous system—bipolar disorder	0.000237	0.00288	CbGeAlD
Dopamine—CYP1A2—thyroid gland—bipolar disorder	0.000235	0.00286	CbGeAlD
Dopamine—DRD2—nervous system—bipolar disorder	0.000234	0.00285	CbGeAlD
Dopamine—HTR7—cerebellum—bipolar disorder	0.000233	0.00284	CbGeAlD
Dopamine—ADRB1—brain—bipolar disorder	0.000231	0.00281	CbGeAlD
Dopamine—SLC22A3—brain—bipolar disorder	0.000229	0.00279	CbGeAlD
Dopamine—SLC6A4—brain—bipolar disorder	0.000223	0.00272	CbGeAlD
Dopamine—MAOA—cerebellum—bipolar disorder	0.000223	0.00271	CbGeAlD
Dopamine—DRD2—cerebellum—bipolar disorder	0.000221	0.00269	CbGeAlD
Dopamine—MAOB—brain—bipolar disorder	0.000212	0.00258	CbGeAlD
Dopamine—Norepinephrine—DRD2—bipolar disorder	0.00021	0.0565	CrCbGaD
Dopamine—L-DOPA—DRD2—bipolar disorder	0.00021	0.0565	CrCbGaD
Dopamine—SLC22A5—cerebellum—bipolar disorder	0.000205	0.0025	CbGeAlD
Dopamine—HTR1A—brain—bipolar disorder	0.000198	0.00241	CbGeAlD
Dopamine—SLC6A2—brain—bipolar disorder	0.000197	0.00239	CbGeAlD
Dopamine—HTR7—brain—bipolar disorder	0.000189	0.00231	CbGeAlD
Dopamine—MAOA—brain—bipolar disorder	0.000181	0.00221	CbGeAlD
Dopamine—DRD2—brain—bipolar disorder	0.000179	0.00218	CbGeAlD
Dopamine—SLC22A5—brain—bipolar disorder	0.000167	0.00203	CbGeAlD
Dopamine—CYP2D6—nervous system—bipolar disorder	0.000141	0.00171	CbGeAlD
Dopamine—CYP2D6—cerebellum—bipolar disorder	0.000133	0.00161	CbGeAlD
Dopamine—CYP2D6—brain—bipolar disorder	0.000108	0.00131	CbGeAlD
Dopamine—DRD4—Signaling Pathways—DRD1—bipolar disorder	7.89e-06	5.71e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HTR2C—bipolar disorder	7.89e-06	5.71e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ADM—bipolar disorder	7.84e-06	5.67e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—AKR1C4—bipolar disorder	7.82e-06	5.66e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD4—bipolar disorder	7.75e-06	5.6e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CACNA1C—bipolar disorder	7.75e-06	5.6e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NR1D1—bipolar disorder	7.7e-06	5.57e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NTRK2—bipolar disorder	7.67e-06	5.55e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—DRD3—bipolar disorder	7.64e-06	5.53e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TSHB—bipolar disorder	7.64e-06	5.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	7.64e-06	5.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TACR1—bipolar disorder	7.64e-06	5.52e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GSK3A—bipolar disorder	7.6e-06	5.5e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ADCY2—bipolar disorder	7.6e-06	5.5e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—PIK3C2A—bipolar disorder	7.55e-06	5.46e-05	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—POMC—bipolar disorder	7.52e-06	5.44e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—HTR2A—bipolar disorder	7.37e-06	5.33e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NCAN—bipolar disorder	7.37e-06	5.33e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR1A—bipolar disorder	7.35e-06	5.32e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—HTR2A—bipolar disorder	7.3e-06	5.28e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ADCY2—bipolar disorder	7.29e-06	5.27e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—HTR2A—bipolar disorder	7.27e-06	5.26e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—NRG1—bipolar disorder	7.27e-06	5.26e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TCF7L2—bipolar disorder	7.27e-06	5.26e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—SNAP25—bipolar disorder	7.26e-06	5.25e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR1A—bipolar disorder	7.25e-06	5.25e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TAC1—bipolar disorder	7.24e-06	5.24e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SLC5A3—bipolar disorder	7.22e-06	5.22e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—DRD2—bipolar disorder	7.22e-06	5.22e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TRPC3—bipolar disorder	7.21e-06	5.22e-05	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—POMC—bipolar disorder	7.2e-06	5.21e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TAC1—bipolar disorder	7.14e-06	5.17e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR2C—bipolar disorder	7.1e-06	5.14e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—MTHFR—bipolar disorder	7.09e-06	5.13e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NR1D1—bipolar disorder	7.09e-06	5.13e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—POMC—bipolar disorder	7.07e-06	5.12e-05	CbGpPWpGaD
Dopamine—COMT—Metabolism—INS—bipolar disorder	7.04e-06	5.09e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NR1D1—bipolar disorder	7.02e-06	5.08e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR2C—bipolar disorder	7.01e-06	5.07e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD1—bipolar disorder	7.01e-06	5.07e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	6.98e-06	5.05e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ADCY2—bipolar disorder	6.98e-06	5.05e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TCF7L2—bipolar disorder	6.96e-06	5.03e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—DRD2—bipolar disorder	6.91e-06	5e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NTRK2—bipolar disorder	6.91e-06	5e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NDUFV2—bipolar disorder	6.9e-06	4.99e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ADM—bipolar disorder	6.88e-06	4.98e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD3—bipolar disorder	6.88e-06	4.97e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GSK3A—bipolar disorder	6.85e-06	4.95e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—POMC—bipolar disorder	6.83e-06	4.94e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NTRK2—bipolar disorder	6.81e-06	4.93e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NCAN—bipolar disorder	6.78e-06	4.9e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—SNAP25—bipolar disorder	6.77e-06	4.9e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GSK3A—bipolar disorder	6.75e-06	4.89e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NCAN—bipolar disorder	6.72e-06	4.86e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—POMC—bipolar disorder	6.71e-06	4.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TSHB—bipolar disorder	6.71e-06	4.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—PDE4B—bipolar disorder	6.71e-06	4.85e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TACR1—bipolar disorder	6.71e-06	4.85e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—AKR1C4—bipolar disorder	6.68e-06	4.83e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD4—bipolar disorder	6.68e-06	4.83e-05	CbGpPWpGaD
Dopamine—MAOB—Metabolism—INS—bipolar disorder	6.67e-06	4.82e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SLC5A3—bipolar disorder	6.64e-06	4.8e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—HTR2A—bipolar disorder	6.63e-06	4.79e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR1A—bipolar disorder	6.61e-06	4.78e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD4—bipolar disorder	6.59e-06	4.76e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SLC5A3—bipolar disorder	6.58e-06	4.76e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—HTR2A—bipolar disorder	6.56e-06	4.74e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—POMC—bipolar disorder	6.54e-06	4.73e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NTRK1—bipolar disorder	6.53e-06	4.73e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—COMT—bipolar disorder	6.51e-06	4.71e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TAC1—bipolar disorder	6.51e-06	4.71e-05	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—POMC—bipolar disorder	6.48e-06	4.69e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ADCY2—bipolar disorder	6.43e-06	4.65e-05	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—POMC—bipolar disorder	6.4e-06	4.63e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD1—bipolar disorder	6.38e-06	4.62e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR2C—bipolar disorder	6.38e-06	4.62e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—S100B—bipolar disorder	6.35e-06	4.59e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	6.34e-06	4.59e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ADCY2—bipolar disorder	6.28e-06	4.55e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TCF7L2—bipolar disorder	6.26e-06	4.53e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NTRK1—bipolar disorder	6.25e-06	4.52e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TAC1—bipolar disorder	6.23e-06	4.5e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—DRD2—bipolar disorder	6.22e-06	4.5e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NTRK2—bipolar disorder	6.21e-06	4.49e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ADCY2—bipolar disorder	6.2e-06	4.48e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD3—bipolar disorder	6.18e-06	4.47e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TCF7L2—bipolar disorder	6.18e-06	4.47e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GSK3A—bipolar disorder	6.15e-06	4.45e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—DRD2—bipolar disorder	6.14e-06	4.44e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—HTR2A—bipolar disorder	6.13e-06	4.43e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD1—bipolar disorder	6.11e-06	4.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	6.11e-06	4.42e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—S100B—bipolar disorder	6.08e-06	4.4e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NR1D1—bipolar disorder	6e-06	4.34e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD4—bipolar disorder	6e-06	4.34e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ADCY2—bipolar disorder	5.99e-06	4.33e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	5.94e-06	4.3e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD3—bipolar disorder	5.91e-06	4.28e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—POMC—bipolar disorder	5.89e-06	4.26e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	5.89e-06	4.26e-05	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—POMC—bipolar disorder	5.83e-06	4.22e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—POMC—bipolar disorder	5.81e-06	4.2e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NCAN—bipolar disorder	5.74e-06	4.15e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD4—bipolar disorder	5.74e-06	4.15e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—POMC—bipolar disorder	5.67e-06	4.1e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ADCY2—bipolar disorder	5.65e-06	4.09e-05	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—INS—bipolar disorder	5.64e-06	4.08e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NTRK1—bipolar disorder	5.63e-06	4.07e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TCF7L2—bipolar disorder	5.63e-06	4.07e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SLC5A3—bipolar disorder	5.62e-06	4.07e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—NRG1—bipolar disorder	5.61e-06	4.05e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—DRD2—bipolar disorder	5.59e-06	4.04e-05	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	5.58e-06	4.03e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—HTR2A—bipolar disorder	5.57e-06	4.03e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NTRK1—bipolar disorder	5.56e-06	4.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR1A—bipolar disorder	5.55e-06	4.02e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—COMT—bipolar disorder	5.51e-06	3.98e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—S100B—bipolar disorder	5.47e-06	3.96e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MAOA—bipolar disorder	5.47e-06	3.95e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TAC1—bipolar disorder	5.47e-06	3.95e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	5.4e-06	3.91e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—S100B—bipolar disorder	5.4e-06	3.91e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	5.38e-06	3.9e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—NRG1—bipolar disorder	5.37e-06	3.88e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD1—bipolar disorder	5.36e-06	3.88e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR2C—bipolar disorder	5.36e-06	3.88e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—DRD2—bipolar disorder	5.35e-06	3.87e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—POMC—bipolar disorder	5.29e-06	3.83e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—GSK3B—bipolar disorder	5.28e-06	3.82e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—MTHFR—bipolar disorder	5.26e-06	3.81e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—POMC—bipolar disorder	5.24e-06	3.79e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CLOCK—bipolar disorder	5.22e-06	3.78e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NTRK2—bipolar disorder	5.21e-06	3.77e-05	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—INS—bipolar disorder	5.21e-06	3.77e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD3—bipolar disorder	5.19e-06	3.76e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GSK3A—bipolar disorder	5.17e-06	3.74e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—COMT—bipolar disorder	5.13e-06	3.71e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MAOA—bipolar disorder	5.09e-06	3.69e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TSHB—bipolar disorder	5.09e-06	3.68e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—TPH2—bipolar disorder	5.09e-06	3.68e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CACNB2—bipolar disorder	5.09e-06	3.68e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—POMC—bipolar disorder	5.06e-06	3.66e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NTRK1—bipolar disorder	5.06e-06	3.66e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—HTR2A—bipolar disorder	5.05e-06	3.66e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—DRD4—bipolar disorder	5.04e-06	3.65e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—DPYD—bipolar disorder	5e-06	3.62e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—S100B—bipolar disorder	4.92e-06	3.56e-05	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—POMC—bipolar disorder	4.9e-06	3.54e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	4.84e-06	3.5e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—HTR2A—bipolar disorder	4.84e-06	3.5e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—NRG1—bipolar disorder	4.83e-06	3.49e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CLOCK—bipolar disorder	4.8e-06	3.47e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—NRG1—bipolar disorder	4.77e-06	3.45e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CLOCK—bipolar disorder	4.76e-06	3.44e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ADCY2—bipolar disorder	4.74e-06	3.43e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TCF7L2—bipolar disorder	4.73e-06	3.42e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—S100B—bipolar disorder	4.71e-06	3.4e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TPH2—bipolar disorder	4.68e-06	3.38e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—TSHB—bipolar disorder	4.68e-06	3.38e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CACNB2—bipolar disorder	4.68e-06	3.38e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CACNA1C—bipolar disorder	4.65e-06	3.36e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TPH2—bipolar disorder	4.64e-06	3.35e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—TSHB—bipolar disorder	4.64e-06	3.35e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CACNB2—bipolar disorder	4.64e-06	3.35e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—DPYD—bipolar disorder	4.6e-06	3.33e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—DPYD—bipolar disorder	4.56e-06	3.3e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—PIK3C2A—bipolar disorder	4.53e-06	3.28e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.47e-06	3.24e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—MTHFR—bipolar disorder	4.45e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—POMC—bipolar disorder	4.45e-06	3.22e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—HTR2A—bipolar disorder	4.36e-06	3.15e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—NRG1—bipolar disorder	4.34e-06	3.14e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—HTR2A—bipolar disorder	4.3e-06	3.11e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CACNA1C—bipolar disorder	4.28e-06	3.09e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NTRK1—bipolar disorder	4.25e-06	3.08e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CACNA1C—bipolar disorder	4.24e-06	3.07e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—POMC—bipolar disorder	4.21e-06	3.04e-05	CbGpPWpGaD
Dopamine—MAOA—Metabolism—INS—bipolar disorder	4.18e-06	3.03e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	4.17e-06	3.02e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—NRG1—bipolar disorder	4.15e-06	3e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—MTHFR—bipolar disorder	4.15e-06	3e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	4.13e-06	2.99e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—S100B—bipolar disorder	4.13e-06	2.99e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	4.08e-06	2.95e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—GSK3B—bipolar disorder	4.07e-06	2.94e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CLOCK—bipolar disorder	4.07e-06	2.94e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SNAP25—bipolar disorder	4.07e-06	2.94e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—POMC—bipolar disorder	4.04e-06	2.92e-05	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—INS—bipolar disorder	4.01e-06	2.9e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CACNB2—bipolar disorder	3.96e-06	2.87e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TPH2—bipolar disorder	3.96e-06	2.87e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—TSHB—bipolar disorder	3.96e-06	2.87e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—HTR2A—bipolar disorder	3.92e-06	2.83e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—DPYD—bipolar disorder	3.9e-06	2.82e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—GSK3B—bipolar disorder	3.9e-06	2.82e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—POMC—bipolar disorder	3.86e-06	2.8e-05	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—INS—bipolar disorder	3.84e-06	2.78e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	3.75e-06	2.71e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SNAP25—bipolar disorder	3.74e-06	2.71e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SNAP25—bipolar disorder	3.71e-06	2.68e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—NRG1—bipolar disorder	3.65e-06	2.64e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CACNA1C—bipolar disorder	3.62e-06	2.62e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ADCY2—bipolar disorder	3.6e-06	2.6e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—POMC—bipolar disorder	3.56e-06	2.57e-05	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—INS—bipolar disorder	3.54e-06	2.56e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—PIK3C2A—bipolar disorder	3.53e-06	2.56e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—GSK3B—bipolar disorder	3.51e-06	2.54e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	3.48e-06	2.52e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—POMC—bipolar disorder	3.48e-06	2.52e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—GSK3B—bipolar disorder	3.46e-06	2.5e-05	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—INS—bipolar disorder	3.46e-06	2.5e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—POMC—bipolar disorder	3.43e-06	2.48e-05	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—INS—bipolar disorder	3.41e-06	2.47e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—POMC—bipolar disorder	3.32e-06	2.4e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ADCY2—bipolar disorder	3.31e-06	2.39e-05	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—INS—bipolar disorder	3.3e-06	2.39e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—HTR2A—bipolar disorder	3.29e-06	2.38e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ADCY2—bipolar disorder	3.28e-06	2.37e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SNAP25—bipolar disorder	3.17e-06	2.29e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—GSK3B—bipolar disorder	3.15e-06	2.28e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—POMC—bipolar disorder	3.13e-06	2.26e-05	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—INS—bipolar disorder	3.11e-06	2.25e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—COMT—bipolar disorder	3.08e-06	2.23e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MAOA—bipolar disorder	3.06e-06	2.21e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	3.02e-06	2.18e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—POMC—bipolar disorder	2.99e-06	2.16e-05	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—INS—bipolar disorder	2.97e-06	2.15e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—COMT—bipolar disorder	2.83e-06	2.05e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MAOA—bipolar disorder	2.81e-06	2.04e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—COMT—bipolar disorder	2.81e-06	2.03e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ADCY2—bipolar disorder	2.8e-06	2.03e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MAOA—bipolar disorder	2.79e-06	2.02e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—GSK3B—bipolar disorder	2.65e-06	1.92e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—POMC—bipolar disorder	2.63e-06	1.9e-05	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—INS—bipolar disorder	2.61e-06	1.89e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—MTHFR—bipolar disorder	2.49e-06	1.8e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—COMT—bipolar disorder	2.4e-06	1.74e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MAOA—bipolar disorder	2.38e-06	1.72e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—MTHFR—bipolar disorder	2.29e-06	1.66e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—MTHFR—bipolar disorder	2.27e-06	1.64e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—POMC—bipolar disorder	1.99e-06	1.44e-05	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—INS—bipolar disorder	1.98e-06	1.43e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—MTHFR—bipolar disorder	1.94e-06	1.4e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—POMC—bipolar disorder	1.83e-06	1.33e-05	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—INS—bipolar disorder	1.82e-06	1.32e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—POMC—bipolar disorder	1.82e-06	1.31e-05	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—INS—bipolar disorder	1.81e-06	1.31e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—POMC—bipolar disorder	1.55e-06	1.12e-05	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—INS—bipolar disorder	1.54e-06	1.12e-05	CbGpPWpGaD
